Mkt, Stem Cells Pull Back Tuesday 8.11

Tuesday 8.11.09: DOW -96(-1%)@9,241..NAS -22.5(-1.1%)@1,970..SP500 -12.75(-1.3%)@994

BIO-Stem Index: -1.8@140.4 (-1.27% today, +40.4% ytd)
BIO-ETF Index: -.35@109.9 (-.32% today, +9.9% ytd)
[Stem cell index beating biotech by 27.7%, the gap is closing]

Now suddenly, in spite of the jobs report, "the market is ahead of itself, needs to correct".. Ok, the market manipulators have spoken, and all the indices fell over 1% each today. Our stem cell index fell 1.3% also, but the ETF's only fell .3%, having a lower beta as a group. Only 9 stem cell stocks rose today, 22 fell. OPXA gave back 13.5% more of its gains. AVNR rose 29.7% (80% intraday) on good Phase III results of a drug for emotional outbursts due to neurological disorders ( Reuters story here ). JAV fell 27.5% on disappointing results for its interim pain drug.

Stem Cell Stocks (9 up, 22 down, 1 unch.)
Big Winners: AMGN +2.6%, ATHX +2%, CRA +2.4%, CUR +5.7%
Losers: ASTM -5%, ARIA -4.3%, AVII -4.1%, CRIS -4.1%, OPXA -13.5%, SQNM -5.5%

Swine Flu Stocks
AVII -4.1%, BCRX -2.8%, DVAX -1.8%, GILD -.8%, INHX -4.3%, INO -3.9%, NVAX -2.8%, SIGA -1.1%, SVA +.4%

Other Biotech
Big Winners: ANDS +5.9%, AVNR +29.7%, GTCB +5%, HGSI +5.8%, JAZZ +6.9%, MNOV +11.1%, ONCY +13.9%, SUPG +6.7%
Losers: AGEN -4.2%, ARIA -4.3%, CBI -6.1%, CERS -5.3%, CPD -6.5%, CRME -8.2%, DCTH -5.8%, DSCO -4.1%, ELRN -4.7%, IMMU -6.2%, JAV -27.5%, KVA -7.4%, NVGN -5%, PLX -4.6%, QGLY -4.3%, RPRX -12.6%, SGEN -7.2%, SOMX -4.7%, TISA -6.3%, YMI -8.7%

Disclosure: long AVNR, GERN, ONXX, FAS.